Crestline Management »

Travere Therapeutics shares owned by Crestline Management

Quarter-by-quarter ownership of Travere Therapeutics (TVTX) shares owned by Crestline Management from 13F filings

Historical chart of Crestline Management investment in Travere Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Travere Therapeutics held by Crestline Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Travere Therapeutics by Crestline Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $732k 81k 8.99
2023-09-30 $549k 61k 8.94
2023-06-30 $943k 61k 15.36
2023-03-31 $1.3M 60k 22.49
2022-06-30 $1.1M 44k 24.23
2022-03-31 $996k 39k 25.77